Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Equity Ratio (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Equity Ratio for 4 consecutive years, with 0.95 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Equity Ratio changed 0.28% year-over-year to 0.95, compared with a TTM value of 0.95 through Sep 2023, changed 0.28%, and an annual FY2022 reading of 0.96, up 1.16% over the prior year.
  • Equity Ratio was 0.95 for Q3 2023 at Terns Pharmaceuticals, up from 0.95 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.96 in Q4 2022 and bottomed at 1.27 in Q4 2020.
  • Average Equity Ratio over 4 years is 0.77, with a median of 0.95 recorded in 2021.
  • The sharpest move saw Equity Ratio surged 174.95% in 2021, then decreased 1.79% in 2022.
  • Year by year, Equity Ratio stood at 1.27 in 2020, then soared by 174.95% to 0.95 in 2021, then increased by 1.16% to 0.96 in 2022, then decreased by 1.42% to 0.95 in 2023.
  • Business Quant data shows Equity Ratio for TERN at 0.95 in Q3 2023, 0.95 in Q2 2023, and 0.95 in Q1 2023.